Nordic Nanovector ASA – Results for Fourth Quarter and Full Year 2016
A year of significant progress with operations on track, new projects to initiate in 2017Oslo, Norway, 28 February 2017 Nordic Nanovector ASA (OSE: NANO) announces its results for the fourth quarter and full year 2016. A presentation of the results by the company’s senior management team will take place today at 8:30 a.m. CET in Oslo - details below. 2016 was a very successful year for Nordic Nanovector. We achieved important milestones with regard to the clinical development of Betalutin®, progressed with our preclinical candidates and build the foundation of R&D innovation and